Role of Epithelial Barrier Integrity in Biologic Treatment Response of Severe Asthmatics With/Out Chronic Rhinosinusitis With Nasal Polyps (CRSwNP).
NCT05365841
·
clinicaltrials.gov ↗
UNKNOWN
Status
85
Enrollment
OTHER
Sponsor class
Conditions
Severe Eosinophilic Asthma w/wo CRSwNP
Interventions
DRUG:
Mepolizumab 100 MG
Sponsor
University of Crete